510 related articles for article (PubMed ID: 33057917)
1. QuantiFERON®-TB Gold In-Tube test can be used for screening latent tuberculosis before biological treatment in a Bacille Calmette-Guérin (BCG)-vaccinated country: the HUR-BIO single-center real-life results.
Seyhoglu E; Uyaroğlu OA; Erden A; Kilic L; Karadag O; Akdogan A; Bilgen SA; Ertenli I; Kiraz S; Kalyoncu U
Clin Rheumatol; 2021 May; 40(5):2027-2035. PubMed ID: 33057917
[TBL] [Abstract][Full Text] [Related]
2. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
Matsumoto T; Yamazaki T
Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
[TBL] [Abstract][Full Text] [Related]
3. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
[TBL] [Abstract][Full Text] [Related]
4. Two interferon gamma release assays for predicting active tuberculosis: the UK PREDICT TB prognostic test study.
Abubakar I; Lalvani A; Southern J; Sitch A; Jackson C; Onyimadu O; Lipman M; Deeks JJ; Griffiths C; Bothamley G; Kon OM; Hayward A; Lord J; Drobniewski F
Health Technol Assess; 2018 Oct; 22(56):1-96. PubMed ID: 30334521
[TBL] [Abstract][Full Text] [Related]
5. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
Calzada-Hernández J; Anton J; Martín de Carpi J; López-Montesinos B; Calvo I; Donat E; Núñez E; Blasco Alonso J; Mellado MJ; Baquero-Artigao F; Leis R; Vegas-Álvarez AM; Medrano San Ildefonso M; Pinedo-Gago MDC; Eizaguirre FJ; Tagarro A; Camacho-Lovillo M; Pérez-Gorricho B; Gavilán-Martín C; Guillén S; Sevilla-Pérez B; Peña-Quintana L; Mesa-Del-Castillo P; Fortuny C; Tebruegge M; Noguera-Julian A
Eur J Pediatr; 2023 Jan; 182(1):307-317. PubMed ID: 36335186
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
Lin WC; Lin HH; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
J Microbiol Immunol Infect; 2016 Oct; 49(5):729-736. PubMed ID: 25442858
[TBL] [Abstract][Full Text] [Related]
7. Agreement between QuantiFERON®-TB Gold In-Tube and the tuberculin skin test and predictors of positive test results in Warao Amerindian pediatric tuberculosis contacts.
Verhagen LM; Maes M; Villalba JA; d'Alessandro A; Rodriguez LP; España MF; Hermans PW; de Waard JH
BMC Infect Dis; 2014 Jul; 14():383. PubMed ID: 25012075
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the QuantiFERON-TB Gold In-Tube test with the tuberculin skin test for detecting latent tuberculosis infection prior to hematopoietic stem cell transplantation.
Moon SM; Lee SO; Choi SH; Kim YS; Woo JH; Yoon DH; Suh C; Kim DY; Lee JH; Lee JH; Lee KH; Kim SH
Transpl Infect Dis; 2013 Feb; 15(1):104-9. PubMed ID: 22823749
[TBL] [Abstract][Full Text] [Related]
9. Accurate diagnosis of latent tuberculosis in children, people who are immunocompromised or at risk from immunosuppression and recent arrivals from countries with a high incidence of tuberculosis: systematic review and economic evaluation.
Auguste P; Tsertsvadze A; Pink J; Court R; Seedat F; Gurung T; Freeman K; Taylor-Phillips S; Walker C; Madan J; Kandala NB; Clarke A; Sutcliffe P
Health Technol Assess; 2016 May; 20(38):1-678. PubMed ID: 27220068
[TBL] [Abstract][Full Text] [Related]
10. Quantitative IFN-γ Release Assay and Tuberculin Skin Test Results to Predict Incident Tuberculosis. A Prospective Cohort Study.
Gupta RK; Lipman M; Jackson C; Sitch AJ; Southern J; Drobniewski F; Deeks JJ; Tsou CY; Griffiths C; Davidson J; Campbell C; Stirrup O; Noursadeghi M; Kunst H; Haldar P; Lalvani A; Abubakar I
Am J Respir Crit Care Med; 2020 Apr; 201(8):984-991. PubMed ID: 31825645
[No Abstract] [Full Text] [Related]
11. QuantiFERON-TB Gold In-Tube Test in the Diagnosis of Latent Tuberculosis Infection in Arthritis Patients Treated with Tumor Necrosis Factor Antagonists.
Baričević D; Popović Grle S; Morović Vergles J; Čuković Čavka S; Jakopović M; Redžepi G; Boras Z; Baričević M; Samaržija M
Acta Clin Croat; 2017 Jun; 56(2):203-209. PubMed ID: 29485786
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the usefulness of interferon-gamma release assays and the tuberculin skin test for the detection of latent Mycobacterium tuberculosis infections in Korean rheumatic patients who are candidates for biologic agents.
Kim JH; Won S; Choi CB; Sung YK; Song GG; Bae SC
Int J Rheum Dis; 2015 Mar; 18(3):315-22. PubMed ID: 25351815
[TBL] [Abstract][Full Text] [Related]
13. QuantiFERON®-TB Gold In-Tube for contact screening in BCG-vaccinated adults: A longitudinal cohort study.
Muñoz L; Gonzalez L; Soldevila L; Dorca J; Alcaide F; Santin M
PLoS One; 2017; 12(8):e0183258. PubMed ID: 28854216
[TBL] [Abstract][Full Text] [Related]
14. Performance of QuantiFERON-TB Gold In-Tube test and Tuberculin Skin Test for diagnosis of latent tuberculosis infection in BCG vaccinated health care workers.
Babayigit C; Ozer B; Ozer C; Inandi T; Duran N; Gocmen O
Med Sci Monit; 2014 Mar; 20():521-9. PubMed ID: 24681806
[TBL] [Abstract][Full Text] [Related]
15. Performance of Tuberculin Skin Tests and Interferon-γ Release Assays in Children Younger Than 5 Years.
Velasco-Arnaiz E; Soriano-Arandes A; Latorre I; Altet N; Domínguez J; Fortuny C; Monsonís M; Tebruegge M; Noguera-Julian A
Pediatr Infect Dis J; 2018 Dec; 37(12):1235-1241. PubMed ID: 30408005
[TBL] [Abstract][Full Text] [Related]
16. Cost-effectiveness of Quantiferon®-TB Gold-in-Tube versus tuberculin skin testing for contact screening and treatment of latent tuberculosis infection in Brazil.
Steffen RE; Caetano R; Pinto M; Chaves D; Ferrari R; Bastos M; de Abreu ST; Menzies D; Trajman A
PLoS One; 2013; 8(4):e59546. PubMed ID: 23593145
[TBL] [Abstract][Full Text] [Related]
17. Comparison of latent tuberculosis infection screening strategies before tumor necrosis factor inhibitor treatment in inflammatory arthritis: IGRA-alone versus combination of TST and IGRA.
Jeong DH; Kang J; Jung YJ; Yoo B; Lee CK; Kim YG; Hong S; Shim TS; Jo KW
PLoS One; 2018; 13(7):e0198756. PubMed ID: 29975703
[TBL] [Abstract][Full Text] [Related]
18. [Tuberculosis screening program for undocumented immigrant teenagers using the QuantiFERON(®)-TB Gold In-Tube test].
Salinas C; Ballaz A; Díez R; Aguirre U; Antón A; Altube L
Med Clin (Barc); 2015 Jul; 145(1):7-13. PubMed ID: 24747025
[TBL] [Abstract][Full Text] [Related]
19. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
[TBL] [Abstract][Full Text] [Related]
20. Comparison of QuantiFERON-TB gold in-tube test with tuberculin skin test in children who had no contact with active tuberculosis case.
Metin Timur Ö; Tanir G; Öz FN; Bayhan Gİ; Aydin Teke T; Tuygun N
Tuberk Toraks; 2014; 62(2):116-21. PubMed ID: 25038380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]